A recent study reveals that individuals who discontinue new weight-loss injections like semaglutide or tirzepatide tend to recover lost weight at a significantly accelerated pace than those who end conventional diet and exercise regimens.
Findings released in a prominent health publication demonstrates that while obese people frequently drop substantial amounts of their total mass while on the medication, the weight is regained at an estimated rate of 0.8 kg per month once they quit.
"People buying these treatments need to be aware of the risk of quick rebound weight gain when the therapy is stopped," warns researcher Dr. Susan Jebb.
Such speed of regain means a reversion to original mass within about 18 months.
Analyzing Therapies
The study, which examined dozens of trials involving thousands of patients, contrasted the results of these new drugs with older methods.
Researchers point out that people who shed pounds through lifestyle changes alone generally have a less rapid weight regain—around 100 grams monthly—after stopping.
The Reason for the Quick Rebound
Doctors believe the mechanism of the drugs explains the amplified rebound.
The injections imitate a body's own chemical called GLP-1, which controls feelings of fullness.
"Long-term administration of GLP-1 concentrations several times higher than the body's typical production might result in the system to produce less of its own natural GLP-1, and could diminish sensitivity to its actions," said Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this GLP-1 'fix' means hunger is uncontrolled, making excessive eating a significant risk."
An Ongoing Condition?
Medical guidelines advise the jabs for people with weight-linked medical conditions, accompanied by prescribed lifestyle changes.
Professionals argue that, given the significant potential of weight regain, the therapy might need to be long-term.
This opinion is reinforced by pharmaceutical companies, who say that the findings "emphasize the persistent character of excess weight," comparing it to managing conditions like high blood pressure.
User Accounts
Individuals who have stopped the jabs explain a sudden resurgence of hunger.
"I experienced a trigger activating and you become ravenous," recalled one woman.
This challenge is exacerbated if users have not adopted sustainable lifestyle or habit changes during treatment.
Growing Interest
Survey data suggest that millions of adults in the UK have tried weight-loss jabs in the past year, with interest remaining high.
- Adoption is more common among women than men.
- The 40s and 50s demographic shows the greatest usage rates.
- A large proportion access the medications through private prescriptions rather than the NHS.
Finally, experts stress that while these medications are effective tools for shedding pounds, they are not a permanent solution and maintained weight loss relies on ongoing lifestyle changes.
